Translation Of “New Biology” Into Clinical Use Identified By DeVita As NCI’s Major Challenge
In Brief: James Carr Replaces Murphy As Interim Director of Organ Systems Coordinating Center In N.Y.
CDC Warns Burton Patients Of Risk Of HTLV-3 Infection
Smokeless Tobacco Consensus Conference Slates in Health Risks
Cancer Letter Goes On Vacation
NCI Advisory Group, Other Cancer Meetings
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - In The Headlines: Private funding can’t replace federal funding—but it can help
- Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed